期刊文献+

维持性血液透析并发腰椎棕色瘤1例

Maintenance hemodialysis complicated with lumbar brown tumor:a case report
下载PDF
导出
摘要 血液透析是慢性肾衰竭一种有效的治疗手段,但不能有效纠正慢性肾衰竭所致的钙磷代谢紊乱,也不能阻止继发性甲状旁腺功能亢进的发生,使之成为影响维持性血液透析患者透析质量和生活质量的重要因素。棕色瘤是血液透析患者较为少见的并发症,容易与骨肉瘤、骨巨细胞瘤、骨转移瘤等相混淆,临床医师需要完善实验室检查和影像资料,做出明确诊断,制定精准治疗方案。通过本例病案报告分析以期提高临床医师对棕色瘤的了解和重视。 Hemodialysis is an effective treatment for chronic renal failure,but it can not effectively correct the disorder of calcium and phosphorus metabolism caused by chronic renal failure,nor can it prevent the occurrence of secondary hyperparathyroidism,making it an important factor affecting the quality of dialysis and life of maintenance hemodialysis patients.Brown tumor is a rare complication in hemodialysis patients,which is easy to be confused with osteosarcoma,giant cell tumor of bone and bone metastatic tumor.Clinicians need to improve laboratory examination and imaging data,make clear diagnosis and formulate accurate treatment plan.This case report aims to improve the clinicians′understanding and attention to brown tumor.
作者 张履鑫 杨钊田 冷伟 杜治锋 Zhang Lyuxin;Yang Zhaotian;Leng Wei;Du Zhifeng(Department of Rheumatology and Immunology,Affiliated Hospital of Shaanxi University of Chinese Medicine,Xianyang 712000,China)
出处 《中国医药》 2022年第6期913-915,共3页 China Medicine
基金 陕西省中医药管理局中医学术流派传承工作室(建设)项目(2018-40-5)。
关键词 维持性血液透析 棕色瘤 钙磷代谢 Maintenance hemodialysis Brown tumor Calcium and phosphorus metabolism
  • 相关文献

参考文献5

二级参考文献40

  • 1孟迅吾,邢小平,刘书勤,詹志伟,周学瀛,刘怀成,史轶蘩,沙利进,余卫,解毓章.原发性甲状旁腺功能亢进症的诊断(附134例分析)[J].中国医学科学院学报,1994,16(1):13-19. 被引量:44
  • 2<活性维生素D的合理应用>专家协作组.活性维生素D在慢性肾脏病继发性甲旁亢中合理应用的专家共识(修订版)[J].中华肾脏病杂志,2005,21(11):698-699. 被引量:97
  • 3欧三桃,赵安菊,黄颂敏.继发性甲旁亢对慢性肾衰竭患者的影响及治疗进展[J].国际泌尿系统杂志,2006,26(6):831-834. 被引量:9
  • 4孙艳艳,方敬爱.慢性肾衰竭伴甲状旁腺激素升高的相关因素分析[J].中国中西医结合肾病杂志,2006,7(12):700-703. 被引量:11
  • 5Naveh-Many T, Almogi G, Livni N, et al. Estrogen receptors and biologic response in rat parathyroid tissue and C cells[J]. J Clin Invest, 1992,90:2434? 438.
  • 6Prince RL. Counterpoint estrogen effects on calciotropic hormones and calcium homeostasis[J]. Endocr Rev, 1994, 15:301-309.
  • 7Block GA, Hulbert-Shearon TE, Levin NVV, et al. Association of serum phosphorus and calcium × phosphate product with mortality risk in chronic hemodialysis patients: a national study[J]. Am J Kidney DIS, 1998,31:607-617.
  • 8Block GA, Port FK. Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management[J]. Am J Kidney DIS, 2000,35:1226-1237.
  • 9National Kidney Foundation. K/DOQI:Clinical practice guidelines for bone metabolism and disease in chronic kidney disease[J]. Am J Kidney Dis, 2003,42:S1-201.
  • 10Spasovski GB, Bervoets AR, Behets GJ, etal. Spectrum of renal bone disease in end - stage renal failure patients net yet on dialysis[J]. Nephrol Dial Transplant, 2003, 18: 1159-1166.

共引文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部